Class IIOngoing

Wegovy (semaglutide) Injection recall

FDA recall D-0244-2026 · initiated Dec 19, 2025

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Presence of Particulate Matter: Hair was found in a prefilled syringe

Details

Product: Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4505-14
Recalling company: Novo Nordisk
Classification: Class II
Status: Ongoing
Type: Voluntary: Firm initiated
Distribution: Nationwide within the United States.
Initiated: Dec 19, 2025
FDA report date: Jan 7, 2026

This recall is linked to a product we cover: Wegovy Hd →

What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Source: openFDA Drug Enforcement record D-0244-2026 ↗

← All drug recalls